LCG
ITCI
Lisanti Capital Growth’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72,600
| Closed | -$6.06M | – | 165 |
|
|
2024
Q4 | $6.06M | Buy |
72,600
+14,485
| +25% | +$1.21M | 1.46% | 16 |
|
|
2024
Q3 | $4.25M | Sell |
58,115
-24,760
| -30% | -$1.81M | 1.08% | 39 |
|
|
2024
Q2 | $5.68M | Buy |
82,875
+29,590
| +56% | +$2.03M | 1.36% | 23 |
|
|
2024
Q1 | $3.69M | Buy |
53,285
+400
| +0.8% | +$27.7K | 0.9% | 52 |
|
|
2023
Q4 | $3.79M | Buy |
+52,885
| New | +$3.79M | 0.89% | 51 |
|
|
2023
Q3 | – | Sell |
-112,650
| Closed | -$7.13M | – | 183 |
|
|
2023
Q2 | $7.13M | Buy |
112,650
+49,140
| +77% | +$3.11M | 0.99% | 37 |
|
|
2023
Q1 | $3.44M | Sell |
63,510
-51,024
| -45% | -$2.76M | 0.48% | 86 |
|
|
2022
Q4 | $6.06M | Buy |
114,534
+29,950
| +35% | +$1.58M | 0.83% | 47 |
|
|
2022
Q3 | $3.94M | Sell |
84,584
-243,310
| -74% | -$11.3M | 0.53% | 76 |
|
|
2022
Q2 | $18.7M | Buy |
327,894
+49,499
| +18% | +$2.83M | 2.54% | 2 |
|
|
2022
Q1 | $17M | Buy |
+278,395
| New | +$17M | 1.91% | 9 |
|
|
2016
Q3 | – | Sell |
-12,260
| Closed | -$476K | – | 112 |
|
|
2016
Q2 | $476K | Buy |
+12,260
| New | +$476K | 0.72% | 67 |
|